137 related articles for article (PubMed ID: 2232490)
1. Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist.
Xie MH; Liu FY; Wong PC; Timmermans PB; Cogan MG
Kidney Int; 1990 Sep; 38(3):473-9. PubMed ID: 2232490
[TBL] [Abstract][Full Text] [Related]
2. Effects of DuP 753 on proximal nephron and renal transport.
Cogan MG; Xie MH; Liu FY; Wong PC; Timmermans PB
Am J Hypertens; 1991 Apr; 4(4 Pt 2):315S-320S. PubMed ID: 1854458
[TBL] [Abstract][Full Text] [Related]
3. Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.
Cogan MG; Liu FY; Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Nov; 259(2):687-91. PubMed ID: 1941617
[TBL] [Abstract][Full Text] [Related]
4. Role of angiotensin II in glomerulotubular balance.
Liu FY; Cogan MG
Am J Physiol; 1990 Jul; 259(1 Pt 2):F72-9. PubMed ID: 2165360
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II: a potent regulator of acidification in the rat early proximal convoluted tubule.
Liu FY; Cogan MG
J Clin Invest; 1987 Jul; 80(1):272-5. PubMed ID: 3597776
[TBL] [Abstract][Full Text] [Related]
6. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
Hypertension; 1990 May; 15(5):459-68. PubMed ID: 2185150
[TBL] [Abstract][Full Text] [Related]
7. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
[TBL] [Abstract][Full Text] [Related]
8. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
Fenoy FJ; Scicli G; Carretero O; Roman RJ
Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II and renal functional reserve in rats with Goldblatt hypertension.
De Nicola L; Keiser JA; Blantz RC; Gabbai FB
Hypertension; 1992 Jun; 19(6 Pt 2):790-4. PubMed ID: 1592482
[TBL] [Abstract][Full Text] [Related]
10. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
[TBL] [Abstract][Full Text] [Related]
11. Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.
Wong PC; Hart SD; Duncia JV; Timmermans PB
Eur J Pharmacol; 1991 Sep; 202(3):323-30. PubMed ID: 1748155
[TBL] [Abstract][Full Text] [Related]
12. The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis.
Jaiswal N; Diz DI; Tallant EA; Khosla MC; Ferrario CM
Am J Hypertens; 1991 Mar; 4(3 Pt 1):228-33. PubMed ID: 2043299
[TBL] [Abstract][Full Text] [Related]
13. Effect of luminal angiotensin II receptor antagonists on proximal tubule transport.
Quan A; Baum M
Am J Hypertens; 1999 May; 12(5):499-503. PubMed ID: 10342788
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats.
Tofovic SP; Pong AS; Jackson EK
Hypertension; 1991 Dec; 18(6):774-82. PubMed ID: 1743758
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
[TBL] [Abstract][Full Text] [Related]
16. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
[TBL] [Abstract][Full Text] [Related]
17. Modulation by locally produced luminal angiotensin II of proximal tubular sodium reabsorption via an AT1 receptor.
Hiranyachattada S; Harris PJ
Br J Pharmacol; 1996 Oct; 119(4):617-8. PubMed ID: 8904632
[TBL] [Abstract][Full Text] [Related]
18. Endogenous production of angiotensin II modulates rat proximal tubule transport.
Quan A; Baum M
J Clin Invest; 1996 Jun; 97(12):2878-82. PubMed ID: 8675701
[TBL] [Abstract][Full Text] [Related]
19. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors.
Brännström K; Morsing P; Arendshorst WJ
Am J Physiol; 1996 May; 270(5 Pt 2):F749-55. PubMed ID: 8928835
[TBL] [Abstract][Full Text] [Related]
20. Further studies on the selectivity of DuP 753, a nonpeptide angiotensin II receptor antagonist.
Wong PC; Tam SW; Herblin WF; Timmermans PB
Eur J Pharmacol; 1991 Apr; 196(2):201-3. PubMed ID: 1651874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
